How to Cite
Abstract
Almost half of preterm births are caused by inflammatory processes, that’s results in a preterm labor. These babies born in an early stage, makes them highly vulnerable by not having, almost every time, a mature organism, most importantly their respiratory system. Most of them will be in the necessity of supplementary oxygen, treatment, and invasions, like long hospital stay, that at long term will take a higher risk of contagious microorganisms that affects its evolution. Mortality in these kids seems especially elevated on those born before 28 weeks of gestation. Prenatal corticosteroid use has shown the decrease of respiratory morbidity in this population, reducing especially the appearance of transient tachypnea of the newborn and respiratory distress syndrome. The use of corticosteroids is one of the most used therapies in preterm labor and one of the most important for having a good outcome in the newborn. In this article will proceed a bibliographic review about recent studies and consensus about the use of antenatal corticosteroids, as well as its benefits and consequences.
Keywords
References
Gabbe SG, Niebyl JR, Simpson JL. Obstetricia: embarazos normales y de riesgo. Madrid: Elsevier; 2019.
Practice Bulletin No. 171: Management of Preterm Labor. Obstet Gynecol. octubre de 2016;128(4):e155-64.
World Health Organization. Preterm Labor [Internet]. 2018 [citado 5 de agosto de 2020]. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/preterm-birth
da Fonseca EB, Damião R, Moreira DA. Preterm birth prevention. Best Pract Res Clin Obstet Gynaecol. noviembre de 2020;69:40-9.
Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, te Pas A, et al. European Consensus Guidelines on the Management of Respiratory Distress Syndrome – 2019 Update. Neonatology. 2019;115(4):432-50.
Humberg A, Fortmann I, Siller B, Kopp MV, Herting E, Göpel W, et al. Preterm birth and sustained inflammation: consequences for the neonate. Semin Immunopathol. agosto de 2020;42(4):451-68.
The WHO ACTION Trials Collaborators. Antenatal Dexamethasone for Early Preterm Birth in Low-Resource Countries. N Engl J Med. 24 de diciembre de 2020;383(26):2514-25.
Haviv HR, Said J, Mol BW. The place of antenatal corticosteroids in late preterm and early term births. Semin Fetal Neonatal Med. febrero de 2019;24(1):37-42.
Gyamfi-Bannerman C, Thom EA, Blackwell SC, Tita ATN, Reddy UM, Saade GR, et al. Antenatal Betamethasone for Women at Risk for Late Preterm Delivery. N Engl J Med. 7 de abril de 2016;374(14):1311-20.
Patel SS, Ludmir J. Drugs for the Treatment and Prevention of Preterm Labor. Clin Perinatol. junio de 2019;46(2):159-72.
Charles J Lockwood, MD, MHCM. Preterm labor: Clinical findings, diagnostic evaluation, and initial treatment. UpToDate [Internet]. Disponible en: https://www-uptodate-com.binasss.idm.oclc.org/contents/preterm-labor-clinical-findings-diagnostic-evaluation-and-initial-treatment?search=preterm%20labor&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1
Johnston RC, Faulkner M, Carpenter PM, Nael A, Haydel D, Sandman CA, et al. Associations Between Placental Corticotropin–Releasing Hormone, Maternal Cortisol, and Birth Outcomes, Based on Placental Histopathology. Reprod Sci. septiembre de 2020;27(9):1803-11.
Barus EB, Massi N. Cortisol levels and labor outcomes among women in the third trimester of pregnancy. Enferm Clínica. marzo de 2020;30:487-90.
Cunningham FG, Williams JW. Williams obstetricia. 2019.
Briceño-Pérez C, Reyna-Villasmil E, Vigil-De-Gracia P. Antenatal corticosteroid therapy: Historical and scientific basis to improve preterm birth management. Eur J Obstet Gynecol Reprod Biol. marzo de 2019;234:32-7.
Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Pregnancy and Childbirth Group, editor. Cochrane Database Syst Rev [Internet]. 21 de marzo de 2017 [citado 28 de julio de 2021]; Disponible en: https://onlinelibrary.wiley.com/doi/10.1002/14651858.CD004454.pub3
WHO. WHO recommendations on interventions to improve preterm birth outcomes [Internet]. WHO; 2015. Disponible en: https://www.who.int/reproductivehealth/publications/maternal_perinatal_health/preterm-birth-guideline/en/
Dixon C, Too G, Saade G, Gyamfi-Bannerman C. Past and Present: A Review of Antenatal Corticosteroids and Recommendations for Late Preterm Birth Steroids. Am J Perinatol. noviembre de 2018;35(13):1241-50.
Ciapponi A, Klein K, Colaci D, Althabe F, Belizán JM, Deegan A, et al. Dexamethasone versus betamethasone for preterm birth: a systematic review and network meta-analysis. Am J Obstet Gynecol MFM. mayo de 2021;3(3):100312.
Vafaei H, Kaveh Baghbahadorani F, Asadi N, Kasraeian M, Faraji A, Roozmeh S, et al. The impact of betamethasone on fetal pulmonary, umbilical and middle cerebral artery Doppler velocimetry and its relationship with neonatal respiratory distress syndrome. BMC Pregnancy Childbirth. diciembre de 2021;21(1):188.
Crowther CA, Ashwood P, Andersen CC, Middleton PF, Tran T, Doyle LW, et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child Adolesc Health. noviembre de 2019;3(11):769-80.
World Health Organization. WHO Model List of Essential Medicines, 20th List [Internet]. 2017 mar [citado 5 de agosto de 2021]. Report No.: 20th Edition. Disponible en: https://www.who.int/publications/i/item/eml-20
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2021 Array